WARGRAVE PRACTICE
THE SURGERY, VICTORIA ROAD, WARGRAVE, READING
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 24 | 29 | 82.8% | |
| HF 4 | 2011 | 31 | 35 | 88.6% | |
| HF 4 | 2012 | 30 | 42 | 71.4% | |
| HF 4 | 2013 | 41 | 50 | 82.0% | |
| HF004 | 2014 | 34 | 35 | 97.1% | |
| HF004 | 2015 | 42 | 43 | 97.7% | |
| HF004 | 2016 | 50 | 53 | 94.3% | |
| HF004 | 2017 | 52 | 57 | 91.2% | |
| HF004 | 2018 | 54 | 57 | 94.7% | |
| HF004 | 2019 | 54 | 57 | 94.7% | |
| HF004 | 2020 | 52 | 58 | 89.7% | |
| HF006 | 2021 | 59 | 60 | 98.3% | |
| HF006 | 2022 | 51 | 54 | 94.4% | |
| HF006 | 2023 | 47 | 50 | 94.0% |
